Drug discovery: Engineering drug combinations

Nature Chemical Biology

Volumn 6, Issue 5, 2010, Pages 318-319

  Dixon, Scott J ^a   Stockwell, Brent R ^b  

^a Department of Biological Sciences ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; NOCODAZOLE; PREDNISONE; PROTEINASE INHIBITOR; RIBOSOME PROTEIN; RNA DIRECTED DNA POLYMERASE; VINCRISTINE; YELLOW FLUORESCENT PROTEIN;

BIOMEDICAL ENGINEERING; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG TARGETING; ENDOSYMBIONT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SHORT SURVEY;

EID: 77951274718     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.353     Document Type: Short Survey

References (10)

1. Bates, S. Drug Discov. Today 15, 115-120 (2010).
2. Jia, J. et al. Nat. Rev. Drug Discov. 8, 111-128 (2009).
3. Araujo, R.P., Liotta, L.A. & Petricoin, E.F. Nat. Rev. Drug Discov. 6, 871-880 (2007).
4. Palella, F.J. Jr. et al. N. Engl. J. Med. 338, 853-860 (1998).
5. Armitage, J.O. N. Engl. J. Med. 328, 1023-1030 (1993).
6. Kroiss, J. et al. Nat. Chem. Biol. 6, 261-263 (2010).
7. Geva-Zatorsky, N. et al. Cell 140, 643-651 (2010).
8. Sigal, A. et al. Nat. Methods 3, 525-531 (2006).
9. Cohen, A.A. et al. Science 322, 1511-1516 (2008).
10. Lehar, J. et al. Mol. Syst. Biol. 3, 80 (2007).